Ixcela

Ixcela

Biotechnology Research

Beverly, Massachusetts 589 followers

Boston-based biotech company that provides data-driven wellness through a pinprick of blood. *Gut microbiome testing*

About us

Ixcela: The Internal Fitness™ Company helps you look and feel great, improve your athletic performance, and even manage chronic health conditions. Ixcela’s sophisticated gut-health test identifies imbalances in your gut (the “second brain”) and our detailed, individualized wellness regimens allow you to restore your internal fitness. Ixcela Offers - A pinprick gut microbiome test - Actionable results - Individualized fitness plans - Personalized nutrition plans - Recommended supplements As you follow your path to internal fitness, your gut health improves and your nutrition and fitness needs change. Regular retesting will help you adjust your personalized wellness plan and keep improving your internal fitness. What Is Internal Fitness? Our internal biochemistry is affected by our lifestyle choices. Poor internal fitness due to processed foods, unmanaged stress, and insufficient physical activity leads not only to common health issues such as irritable bowel syndrome, acid reflux, and intestinal permeability (often referred to as “leaky gut”) but also to chronic disease. Ixcela allows you to take control of your wellness with specific, actionable steps.

Website
http://www.ixcela.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Beverly, Massachusetts
Type
Privately Held
Founded
2012
Specialties
gut health, metabolomics, microbiome, health, nutrition, biotechnology, science, personalized nutrition, diet, fitness, at-home test, blood test, health and wellness, IBS, weight loss, professional athletes, supplements, gut issues, gut stuff, gut test, gut microbiome, personalized wellness, personalized health, science, gut health research, metabolites, and metabolite testing

Locations

Employees at Ixcela

Updates

Similar pages

Browse jobs

Funding

Ixcela 3 total rounds

Last Round

Series unknown

US$ 3.8M

See more info on crunchbase